En- og- treds patienter fuldførte forsøget (35 patienter modtog den anbefaldede dosis 400/ 100 mg gennem hele forsøget).
Sixty-one patients completed the study (35 patients received the recommended 400/ 100 mg twice daily dose throughout the study).